Progress of T-cell lymphoma treatment
10.3760/cma.j.issn.1009-9921.2017.08.001
- VernacularTitle:T细胞淋巴瘤治疗进展
- Author:
Donglu ZHAO
;
Jun MA
- Keywords:
Lymphoma;
T-cell;
Histone deacetylase inhibitors;
International Conference on Malignant Lymphoma
- From:
Journal of Leukemia & Lymphoma
2017;26(8):449-451
- CountryChina
- Language:Chinese
-
Abstract:
The 14th International Conference on Malignant Lymphoma (ICML) was held in Lugano, Switzerland from June 14, 2017 to June 17, 2017. More than 3500 lymphoma experts and scholars attended this unprecedented conference. In particular, the Joint Forum on Union for China Lymphoma Investigators (UCLI)-ICML jointly organised by UCLI and ICML had greatly improved Chinese academic status in the field of lymphoma worldwide. Chinese experience on the treatment of T-cell lymphoma was exchanged during the conference. This paper reviews the recent progress in treatment of T-cell lymphoma in the meeting.
